Phase 2 Study of AUY922 in NSCLC Patients With Exon 20 Insertion Mutations in EGFR

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2015 by Massachusetts General Hospital
Sponsor:
Information provided by (Responsible Party):
Lecia V. Sequist, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT01854034
First received: May 12, 2013
Last updated: August 7, 2015
Last verified: August 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)